| Year |
Citation |
Score |
| 2023 |
Ben-Jonathan N, Borcherding DC, Hugo ER. Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications. Critical Reviews in Oncogenesis. 27: 51-71. PMID 36734872 DOI: 10.1615/CritRevOncog.2022043641 |
0.768 |
|
| 2021 |
Borcherding DC, Hugo ER, Fox SR, Jacobson EM, Hunt BG, Merino EJ, Ben-Jonathan N. Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor. Cancers. 13. PMID 34071395 DOI: 10.3390/cancers13112662 |
0.78 |
|
| 2019 |
Ben-Jonathan N, Borcherding DC, Fox S, Hugo ER. Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1. Cancer Drug Resistance (Alhambra, Calif.). 2: 933-947. PMID 35582277 DOI: 10.20517/cdr.2019.83 |
0.771 |
|
| 2018 |
Ben-Jonathan N. Dopamine receptor type 1 (D1R) in breast cancer: Expression, signaling and therapeutic applications Journal of Cancer Science & Therapy. 10. DOI: 10.4172/1948-5956-C6-137 |
0.455 |
|
| 2016 |
Tuttle TR, Takiar V, Kumar B, Kumar P, Ben-Jonathan N. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells. Cancer Letters. PMID 28025101 DOI: 10.1016/J.Canlet.2016.12.020 |
0.66 |
|
| 2015 |
Tuttle TR, Mierzwa ML, Wells SI, Fox SR, Ben-Jonathan N. The cyclic GMP/protein kinase g pathway as a therapeutic target in head and neck squamous cell carcinoma. Cancer Letters. PMID 26551887 DOI: 10.1016/J.Canlet.2015.10.024 |
0.664 |
|
| 2015 |
Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, Shaughnessy E, Ben-Jonathan N. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene. PMID 26477316 DOI: 10.1038/Onc.2015.369 |
0.784 |
|
| 2015 |
Garrison JB, Ge C, Che L, Pullum DA, Peng G, Khan S, Ben-Jonathan N, Wang J, Du C. Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents. Journal of Cancer Science & Therapy. 7: 121-126. PMID 26191375 DOI: 10.4172/1948-5956.1000335 |
0.479 |
|
| 2015 |
Ben-Jonathan N, Hugo E. Prolactin (PRL) in adipose tissue: regulation and functions. Advances in Experimental Medicine and Biology. 846: 1-35. PMID 25472532 DOI: 10.1007/978-3-319-12114-7_1 |
0.363 |
|
| 2014 |
Marano RJ, Ben-Jonathan N. Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions. Molecular Endocrinology (Baltimore, Md.). 28: 622-33. PMID 24694306 DOI: 10.1210/Me.2013-1349 |
0.304 |
|
| 2014 |
Tuttle TR, Hugo ER, Tong WS, Ben-Jonathan N. Placental lactogen is expressed but is not translated into protein in breast cancer. Plos One. 9: e87325. PMID 24475273 DOI: 10.1371/Journal.Pone.0087325 |
0.688 |
|
| 2014 |
Tuttle T, Tong W, Casper K, Mierzwa M, Ben-Jonathan N. Expression and Therapeutic Applications of Dopamine Receptors in Head-and-Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 88: 517. DOI: 10.1016/J.Ijrobp.2013.11.168 |
0.673 |
|
| 2013 |
Villarroel P, Reyes M, Fuentes C, Segovia MP, Tobar N, Villalobos E, MartÃnez J, Hugo E, Ben-Jonathan N, Cifuentes M. Adipogenic effect of calcium sensing receptor activation. Molecular and Cellular Biochemistry. 384: 139-45. PMID 24005534 DOI: 10.1007/S11010-013-1791-7 |
0.343 |
|
| 2012 |
Cifuentes M, Fuentes C, Tobar N, Acevedo I, Villalobos E, Hugo E, Ben-Jonathan N, Reyes M. Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue. Molecular and Cellular Endocrinology. 361: 24-30. PMID 22449852 DOI: 10.1016/J.Mce.2012.03.006 |
0.32 |
|
| 2011 |
Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, Loftus J, Ben-Jonathan N. Dopamine receptors in human adipocytes: expression and functions. Plos One. 6: e25537. PMID 21966540 DOI: 10.1371/Journal.Pone.0025537 |
0.753 |
|
| 2011 |
Idelman G, Jacobson EM, Tuttle TR, Ben-Jonathan N. Lactogens and estrogens in breast cancer chemoresistance. Expert Review of Endocrinology & Metabolism. 6: 411-422. PMID 21731573 DOI: 10.1586/Eem.11.19 |
0.735 |
|
| 2011 |
Jacobson EM, Hugo ER, Borcherding DC, Ben-Jonathan N. Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discovery Medicine. 11: 315-24. PMID 21524385 |
0.736 |
|
| 2010 |
Jacobson EM, Hugo ER, Tuttle TR, Papoian R, Ben-Jonathan N. Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor. Trends in Endocrinology and Metabolism: Tem. 21: 691-8. PMID 20846877 DOI: 10.1016/J.Tem.2010.08.004 |
0.706 |
|
| 2010 |
Cifuentes M, Fuentes C, Mattar P, Tobar N, Hugo E, Ben-Jonathan N, Rojas C, MartÃnez J. Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line. Archives of Biochemistry and Biophysics. 500: 151-6. PMID 20595056 DOI: 10.1016/J.Abb.2010.05.033 |
0.321 |
|
| 2010 |
Kansra S, Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N. Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation. Plos One. 5: e10060. PMID 20419096 DOI: 10.1371/Journal.Pone.0010060 |
0.403 |
|
| 2010 |
LaPensee EW, Ben-Jonathan N. Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. Endocrine-Related Cancer. 17: R91-107. PMID 20071456 DOI: 10.1677/Erc-09-0253 |
0.815 |
|
| 2010 |
LaPensee EW, LaPensee CR, Fox S, Schwemberger S, Afton S, Ben-Jonathan N. Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells. Cancer Letters. 290: 167-73. PMID 19796866 DOI: 10.1016/J.Canlet.2009.09.005 |
0.807 |
|
| 2009 |
Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N, Kansra S. Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression. American Journal of Physiology. Endocrinology and Metabolism. 297: E331-9. PMID 19470835 DOI: 10.1152/Ajpendo.00133.2009 |
0.383 |
|
| 2009 |
LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassi el M, Afton SE, Ben-Jonathan N. Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase. Carcinogenesis. 30: 1298-304. PMID 19443905 DOI: 10.1093/Carcin/Bgp120 |
0.807 |
|
| 2009 |
Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Molecular and Cellular Endocrinology. 304: 49-54. PMID 19433247 DOI: 10.1016/J.Mce.2009.02.022 |
0.361 |
|
| 2009 |
Lapensee EW, Tuttle TR, Fox SR, Ben-Jonathan N. Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environmental Health Perspectives. 117: 175-80. PMID 19270784 DOI: 10.1289/Ehp.11788 |
0.791 |
|
| 2009 |
Ben-Jonathan N, Chen S, Dunckley JA, LaPensee C, Kansra S. Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs. Endocrinology. 150: 795-802. PMID 18832099 DOI: 10.1210/En.2008-0756 |
0.444 |
|
| 2008 |
Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environmental Health Perspectives. 116: 1642-7. PMID 19079714 DOI: 10.1289/Ehp.11537 |
0.417 |
|
| 2008 |
Hugo ER, Borcherding DC, Gersin KS, Loftus J, Ben-Jonathan N. Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. The Journal of Clinical Endocrinology and Metabolism. 93: 4006-12. PMID 18647802 DOI: 10.1210/Jc.2008-1172 |
0.733 |
|
| 2008 |
LaPensee CR, Hugo ER, Ben-Jonathan N. Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways. Endocrinology. 149: 5415-22. PMID 18617614 DOI: 10.1210/En.2008-0549 |
0.304 |
|
| 2008 |
Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocrine Reviews. 29: 1-41. PMID 18057139 DOI: 10.1210/Er.2007-0017 |
0.775 |
|
| 2007 |
Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: Regulation of release and putative functions Diabetes, Obesity and Metabolism. 9: 464-476. PMID 17587388 DOI: 10.1111/j.1463-1326.2006.00671.x |
0.334 |
|
| 2007 |
Brandebourg TD, Bown JL, Ben-Jonathan N. Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue. Biochemical and Biophysical Research Communications. 357: 408-13. PMID 17433256 DOI: 10.1016/J.Bbrc.2007.03.168 |
0.422 |
|
| 2007 |
LaPensee EW, Reddy SP, Hugo ER, Schwemberger SJ, Ben-Jonathan N. LS14 cells: a model for chemoresistance in liposarcoma. Cancer Biology & Therapy. 6: 519-24. PMID 17426441 DOI: 10.4161/Cbt.6.4.3816 |
0.778 |
|
| 2006 |
LaPensee CR, Horseman ND, Tso P, Brandebourg TD, Hugo ER, Ben-Jonathan N. The prolactin-deficient mouse has an unaltered metabolic phenotype. Endocrinology. 147: 4638-45. PMID 16809445 DOI: 10.1210/En.2006-0487 |
0.304 |
|
| 2006 |
McFarland-Mancini M, Hugo E, Loftus J, Ben-Jonathan N. Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochemical and Biophysical Research Communications. 344: 9-16. PMID 16630538 DOI: 10.1016/J.Bbrc.2006.03.168 |
0.475 |
|
| 2006 |
Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR. Focus on prolactin as a metabolic hormone. Trends in Endocrinology and Metabolism: Tem. 17: 110-6. PMID 16517173 DOI: 10.1016/J.Tem.2006.02.005 |
0.364 |
|
| 2006 |
Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N. LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology. 147: 306-13. PMID 16195405 DOI: 10.1210/En.2005-0989 |
0.39 |
|
| 2005 |
Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Molecular and Cellular Endocrinology. 239: 27-36. PMID 15950373 DOI: 10.1016/J.Mce.2005.04.008 |
0.482 |
|
| 2003 |
Liby K, Neltner B, Mohamet L, Menchen L, Ben-Jonathan N. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Research and Treatment. 79: 241-52. PMID 12825859 DOI: 10.1023/A:1023956223037 |
0.697 |
|
| 2003 |
Liby K, Neltner B, Mohamet L, Burd C, Ben-Jonathan N. Endostatin expression by MDA-MB-435 breast cancer cells effectively inhibits tumor growth. Cancer Biology & Therapy. 2: 48-52. PMID 12673115 DOI: 10.4161/Cbt.179 |
0.647 |
|
| 2003 |
Hnasko R, Ben-Jonathan N. Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines. Endocrine. 20: 35-44. PMID 12668866 DOI: 10.1385/Endo:20:1-2:35 |
0.388 |
|
| 2003 |
Zinger M, McFarland M, Ben-Jonathan N. Prolactin expression and secretion by human breast glandular and adipose tissue explants. The Journal of Clinical Endocrinology and Metabolism. 88: 689-96. PMID 12574200 DOI: 10.1210/Jc.2002-021255 |
0.455 |
|
| 2002 |
Ben-Jonathan N, Liby K, McFarland M, Zinger M. Prolactin as an autocrine/paracrine growth factor in human cancer. Trends in Endocrinology and Metabolism: Tem. 13: 245-50. PMID 12128285 DOI: 10.1016/S1043-2760(02)00603-3 |
0.668 |
|
| 2002 |
Ben-Jonathan N, Khurana S, Hnasko R. 86 – Brain Prolactin Hormones, Brain and Behavior. 97-120. DOI: 10.1016/B978-012532104-4/50088-3 |
0.381 |
|
| 2001 |
Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor Endocrine Reviews. 22: 724-763. PMID 11739329 DOI: 10.1210/Edrv.22.6.0451 |
0.402 |
|
| 2000 |
Khurana S, Ranmal S, Ben-Jonathan N. Exposure of newborn male and female rats to environmental estrogens: delayed and sustained hyperprolactinemia and alterations in estrogen receptor expression. Endocrinology. 141: 4512-7. PMID 11108262 DOI: 10.1210/Endo.141.12.7823 |
0.373 |
|
| 2000 |
Long X, Steinmetz R, Ben-Jonathan N, Caperell-Grant A, Young PC, Nephew KP, Bigsby RM. Strain differences in vaginal responses to the xenoestrogen bisphenol A. Environmental Health Perspectives. 108: 243-7. PMID 10706531 DOI: 10.1289/Ehp.00108243 |
0.305 |
|
| 1999 |
Khurana S, Liby K, Buckley AR, Ben-Jonathan N. Proteolysis of Human Prolactin: Resistance to Cathepsin D and Formation of a Nonangiostatic, C-Terminal 16K Fragment by Thrombin1. Endocrinology. 140: 4127-4132. PMID 28200812 DOI: 10.1210/endo.140.9.6955 |
0.509 |
|
| 1999 |
Khurana S, Liby K, Buckley AR, Ben-Jonathan N. Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin. Endocrinology. 140: 4127-32. PMID 10465285 DOI: 10.1210/Endo.140.9.6955 |
0.598 |
|
| 1999 |
Mitchner NA, Garlick C, Steinmetz RW, Ben-Jonathan N. Differential regulation and action of estrogen receptors α and β in GH3 cells Endocrinology. 140: 2651-2658. PMID 10342855 DOI: 10.1210/Endo.140.6.6703 |
0.435 |
|
| 1999 |
Khurana S, Kuns R, Ben-Jonathan N. Heparin-binding property of human prolactin: A novel aspect of prolactin biology Endocrinology. 140: 1026-1029. PMID 9927340 DOI: 10.1210/Endo.140.2.6677 |
0.329 |
|
| 1998 |
Mitchner NA, Garlick C, Ben-Jonathan N. Cellular distribution and gene regulation of estrogen receptors α and β in the rat pituitary gland Endocrinology. 139: 3976-3983. PMID 9724053 DOI: 10.1210/Endo.139.9.6181 |
0.429 |
|
| 1998 |
Steinmetz R, Mitchner NA, Grant A, Allen DL, Bigsby RM, Ben-Jonathan N. The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract. Endocrinology. 139: 2741-7. PMID 9607780 DOI: 10.1210/Endo.139.6.6027 |
0.35 |
|
| 1998 |
Ben-Jonathan N, Steinmetz R. Xenoestrogens: The emerging story of bisphenol A Trends in Endocrinology and Metabolism. 9: 124-128. DOI: 10.1016/S1043-2760(98)00029-0 |
0.395 |
|
| 1997 |
Hnasko R, Khurana S, Shackleford N, Steinmetz R, Low MJ, Ben-Jonathan N. Two distinct pituitary cell lines from mouse intermediate lobe tumors: a cell that produces prolactin-regulating factor and a melanotroph [seecomments]. Endocrinology. 138: 5589-96. PMID 9389547 DOI: 10.1210/Endo.138.12.5656 |
0.404 |
|
| 1997 |
Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, Allen RG, Hnasko R, Ben-Jonathan N, Grandy DK, Low MJ. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron. 19: 103-13. PMID 9247267 DOI: 10.1016/S0896-6273(00)80351-7 |
0.366 |
|
| 1997 |
Allen DL, Mitchner NA, Uveges TE, Nephew KP, Khan S, Ben-Jonathan N. Cell-specific induction of c-fos expression in the pituitary gland by estrogen. Endocrinology. 138: 2128-35. PMID 9112413 DOI: 10.1210/Endo.138.5.5101 |
0.383 |
|
| 1997 |
Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology. 138: 1780-6. PMID 9112368 DOI: 10.1210/Endo.138.5.5132 |
0.439 |
|
| 1996 |
Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocrine Reviews. 17: 639-69. PMID 8969972 DOI: 10.1210/Edrv-17-6-639 |
0.367 |
|
| 1995 |
Allen DL, Low MJ, Allen RG, Ben-Jonathan N. Identification of two classes of prolactin-releasing factors in intermediate lobe tumors from transgenic mice. Endocrinology. 136: 3093-9. PMID 7789336 DOI: 10.1210/Endo.136.7.7789336 |
0.307 |
|
| 1995 |
Mershon J, Sall W, Mitchner N, Ben-Jonathan N. Prolactin is a local growth factor in rat mammary tumors Endocrinology. 136: 3619-3623. PMID 7628401 DOI: 10.1210/Endo.136.8.7628401 |
0.405 |
|
| 1994 |
Liu JW, Ben-Jonathan N. Prolactin-releasing activity of neurohypophysial hormones: Structure- function relationship Endocrinology. 134: 114-118. PMID 8275925 DOI: 10.1210/Endo.134.1.8275925 |
0.382 |
|
| 1994 |
Steinmetz R, Gutierrez-Hartmann A, Bigsby RM, Ben-Jonathan N. Activation of the prolactin promoter in transfected GH3 cells by posterior pituitary cells Endocrinology. 135: 2737-2741. PMID 7988465 DOI: 10.1210/Endo.135.6.7988465 |
0.367 |
|
| 1994 |
Baldessarini RJ, Campbell A, Ben-Jonathan N, Ellingboe J, Zong R, Neumeyer JL. Effects of aporphine isomers on rat prolactin. Neuroscience Letters. 176: 269-71. PMID 7830962 DOI: 10.1016/0304-3940(94)90098-1 |
0.329 |
|
| 1993 |
Garris PA, Ben-Jonathan N. A compartmentalized chamber for studying dopamine neurons in an hypothalamo-pituitary explant. Journal of Neuroscience Methods. 49: 113-21. PMID 8271824 DOI: 10.1016/0165-0270(93)90115-8 |
0.637 |
|
| 1992 |
Dymshitz J, Laudon M, Ben-Jonathan N. Endothelin-induced biphasic response of lactotrophs cultured under different conditions. Neuroendocrinology. 55: 724-9. PMID 1630588 DOI: 10.1159/000126192 |
0.315 |
|
| 1991 |
Garris PA, Ben-Jonathan N. Effects of reuptake inhibitors on dopamine release from the stalk-median eminence and posterior pituitary in vitro. Brain Research. 556: 123-9. PMID 1933344 DOI: 10.1016/0006-8993(91)90555-A |
0.617 |
|
| 1991 |
Garris PA, Ben-Jonathan N. Estradiol rapidly stimulates dopamine release from the posterior pituitary in vitro. Neuroendocrinology. 53: 601-7. PMID 1876237 DOI: 10.1159/000125780 |
0.659 |
|
| 1991 |
Ben-Jonathan N, Laudon M, Garris PA. Novel aspects of posterior pituitary function: Regulation of prolactin secretion Frontiers in Neuroendocrinology. 12: 231-277. |
0.593 |
|
| 1990 |
Burgett RA, Garris PA, Ben-Jonathan N. Estradiol-induced prolactinomas: differential effects on dopamine in posterior pituitary and median eminence. Brain Research. 531: 143-7. PMID 2289118 DOI: 10.1016/0006-8993(90)90767-6 |
0.624 |
|
| 1990 |
Garris PA, Ben-Jonathan N. Regulation of dopamine release in vitro from the posterior pituitary by opioid peptides. Neuroendocrinology. 52: 399-404. PMID 1979840 DOI: 10.1159/000125612 |
0.645 |
|
| 1989 |
Arbogas LA, Murai I, Ben-Jonathan N. Differential alterations in dopamine turnover rates in the stalk-median eminence and posterior pituitary during the preovulatory prolactin surge Neuroendocrinology. 49: 525-530. PMID 2725844 DOI: 10.1159/000125162 |
0.354 |
|
| 1989 |
Croxton TL, Armstrong WM, Ben-Jonathan N. Patch clamp recording from anterior pituitary cells identified by reverse hemolytic plaque assay Methods in Enzymology. 168: 144-166. PMID 2657330 DOI: 10.1016/0076-6879(89)68011-1 |
0.327 |
|
| 1989 |
Laudon M, Hyde JF, Ben-Jonathan N. Ontogeny of prolactin releasing and inhibiting activities in the posterior pituitary of male rats Neuroendocrinology. 50: 644-649. PMID 2515464 DOI: 10.1159/000125293 |
0.319 |
|
| 1989 |
Hyde JF, North WG, Ben-Jonathan N. The vasopressin-associated glycopeptide is not a prolactin-releasing factor: Studies with lactating Brattleboro rats Endocrinology. 125: 35-40. PMID 2500328 DOI: 10.1210/Endo-125-1-35 |
0.352 |
|
| 1989 |
Murai I, Garris PA, Ben-Jonathan N. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine. Endocrinology. 124: 2343-9. PMID 2495929 DOI: 10.1210/endo-124-5-2343 |
0.627 |
|
| 1989 |
Murai I, Reichlin S, Ben-Jonathan N. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide Endocrinology. 124: 1050-1055. PMID 2492217 DOI: 10.1210/Endo-124-2-1050 |
0.351 |
|
| 1988 |
Hyde JF, Murai I, Ben-Jonathan N. Differential effects of pituitary stalk-section on posterior pituitary and hypothalamic contents of prolactin-releasing factor, oxytocin, dopamine and beta-endorphin Neuroendocrinology. 48: 314-319. PMID 2972937 DOI: 10.1159/000125028 |
0.381 |
|
| 1987 |
Arbogast LA, Garris PA, Rhoades TA, Ben-Jonathan N. Changes in ovarian norepinephrine synthesis throughout the follicular and luteal phases. Biology of Reproduction. 36: 899-906. PMID 3109517 |
0.571 |
|
| 1986 |
Murai I, Ben-Jonathan N. Chronic posterior pituitary lobectomy: Prolonged elevation of plasma prolactin and interruption of cyclicity Neuroendocrinology. 43: 453-458. PMID 3748304 DOI: 10.1159/000124566 |
0.307 |
|
| 1981 |
Bahr JM, Ben-Jonathan N. Preovulatory depletion of ovarian catecholamines in the rat Endocrinology. 108: 1815-1820. PMID 7215301 DOI: 10.1210/Endo-108-5-1815 |
0.3 |
|
| Show low-probability matches. |